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httpcense.Abstract Background: Signiﬁcant portions of central airway stenosis patients present with unre-
sectable disease. Using bronchotherapeutic procedures to maintain a patent airway and improve
clinical symptoms and quality of life is a well-known armamentarium technique.
Aim: To assess the contribution of different physiological and pathological prognostic factors on
the yield of endobronchial therapies (argon plasma coagulation (APC) and electrocautery) in patients
with central airway obstruction whether derived from malignant or non-malignant etiology.
Patients and methods: Twenty nine patients with central airway obstruction, 21 males and eight
females, were recruited in the study. All the studied patients were categorized into malignant and
non-malignant groups with different pathological varieties. Interventional bronchoscopic procedures
were performed under general anesthesia. The ﬂexible bronchoscopewas either passed via an endotra-
cheal tube or through the rigid bronchoscope. Collected data included patient demographics, evalu-
ation of performance scale and quality of life status, evaluation of dyspnea, cough and hemoptysis
scores before the interventional bronchoscopy and 1 day after the last session. Also the collected data
included; length, size, localization and bronchoscopic appearance of the lesion. Duration of symp-
toms, duration of mechanical ventilation and the presence of collapse prior to the intervention were
all recorded. Number of sessions and type of bronchoscopicmodalities used were recorded. Spiromet-
ric pulmonary function tests were done before and 1 day after the last session.
Results: Complete recanalization was achieved in (17/29) 58.6% of patients, while incomplete or
partial recanalization was achieved in (12/29) 41.4% of patients. Using linear regression analysis of62248163.
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502 R.M.M. Hussein et al.independent factors affecting patient outcome; it was found that the length of lesion followed by
presence of collapse, duration of symptoms and lastly lesion localization whether localized or diffuse
(P< 0.0005), (P< 0.011), (P< 0.02) and (P< 0.039) were the most independent factors affecting
patient outcome.
Conclusion: For favorable outcome, selection of patients with central airway obstructing lesions
candidates for bronchoscopic argon plasma coagulation and/or electrocautery should rely on several
factors including; age, duration of symptoms, performance scale, co-morbidities, pre-therapeutic
FEV1%, presence of lung collapse, and length of the obstructing lesion, moreover its shape and local-
ization.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Introduction
Despite the many options, the management of airway obstruc-
tion from either malignant or nonmalignant causes is a com-
plex problem that requires thorough evaluation by a
multidisciplinary team including interventional broncholo-
gists, thoracic surgeons and chest radiologists [1].
With increasing numbers of lung cancer patients, increased
need for sophisticated interventions in those patients and the
expanding role of the Chest Department, Zagazig University
in its surrounding environment; intervention bronchoscopy
unit with APC and electrocautery was established on 2008.
The aim of this work is to assess the contribution of differ-
ent physiological and pathological prognostic factors on the
yield of endobronchial therapies (argon plasma coagulation
and electrocautery) in patients with central airway obstruction
whether derived from malignant or non-malignant etiology.
Patients and methods
Patients
This study was conducted in the Chest Departments (Bron-
choscopy Units) of the Ain-Shams and the Zagazig University
Hospitals during the period from May 2008 to March 2011.
Twenty nine patients, 21 males and eight females, their age
ranged from 20 to 67 years with a mean age of
50.45 ± 12.14 years were recruited in the study. Patients gave
their signed written consent after detailed explanation of the
technique. All the included patients had a diagnosed tracheal,
bronchial, tracheobronchial or lobar bronchial obstruction.
Inclusion criteria
The main bulk of the lesion was endobronchial, the obstruc-
tion should be at the level of the major airways from the tra-
chea, main bronchi or lobar bronchi, the margin between the
lesion and the airway should be identiﬁed, patients completed
their chemotherapy and/or radiotherapy or did not receive it at
all, the tumors had contraindication to surgery either absolute
or relative in all included patients, and all patients were suffer-
ing from distressing and/or life threatening symptoms related
to the airway obstruction. The main symptoms of the patients
were severe irritating cough, dyspnea or hemoptysis.
Exclusion criteria
Operable tumors without any contraindications to surgery,
presence of severe coagulation defect, orthopneic patients withsevere respiratory distress, patients with extensive myocardial
ischemia in ECG, patients with cardiac arrhythmias, or patients
with extrabronchial main bulk of the tumor were excluded from
the study.
Patients were categorized according to the etiology of
central airway obstruction into two groups: Group I: Malig-
nant group which included 21 patients with malignant air-
way obstruction; they included 17 patients with
bronchogenic carcinoma (three of them were having small
cell lung cancer (SCLC), 13 patients were having non small
cell lung cancer (NSCLC), and one patient with carcinoid
tumor), three patients with endobronchial metastatic cancers,
and one patient with endobronchial lymphoma. Group II:
Non-malignant group which included eight patients with
non-malignant central airway obstruction of which; ﬁve pa-
tients with secondary stenosis to prolonged orotracheal intu-
bation, one patient with tracheal stenosis secondary to
tracheostomy, one patient with endobronchial tuberculosis,
and one patient with Wegener’s granulomatosis (Figs. 1–4).
All patients were submitted to:
1. Thorough medical history including smoking habit. His-
tory of associated illness like diabetes mellitus, hyperten-
sion, ischemic heart disease, history suggestive of COPD
and history of tuberculosis. Evaluation of dyspnea:
Based on the 5-point dyspnea grading system (The
American Thoracic Society dyspnea scale) [2]. Evalua-
tion of cough according to Walsh et al. [3] into the fol-
lowing: Grade 0: No cough Grade 1: Cough does not
disturb sleep. Grade 2: Cough disturbs sleep. Evaluation
of hemoptysis according to Morice et al. [4]: Grade 0:
No hemoptysis. Grade 1: Streaks of blood in sputum.
Grade 2: Clots of blood in sputum in 4 days or less dur-
ing the proceeding 2 weeks. Grade 3: Clots of blood in
sputum in 5 or more days during the proceeding
2 weeks. Grade 4: Hemoptysis requires blood transfu-
sion. Evaluation of dyspnea, cough and hemoptysis
improvement was done before the interventional bron-
choscopy and 1 day after the last session. As regards
hemoptysis; daily estimation of the amount of hemopty-
sis after the procedure was ensured.
2. Full clinical examination: general and local chest
examination.
3. Plain chest X-ray (postero-anterior and lateral views),
before and after each session of the interventional
procedure.
4. Electrocardiography (ECG): It was done before each
session of the interventional procedures.
Figure 1 (a) CT chest mediastinal window demonstrating irregular mass that encroached left main bronchus with distal left lung collapse
and left sided pleural effusion. (b) Virtual bronchoscopy showing totally occluded left main bronchus by endobronchial tumor growth. (c)
Bronchoscopic view showing left main bronchus occlusion by whitish mass lesion. (d) Devitalized tumor tissue, partial reopening of the
left main bronchus, and electrocautery probe. (e) Bronchoscopic view of the partially recanalized left main bronchus after bronchoscopic
electrocautery.
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ture, prothrombin time, partial thromboplastin time and
prothrombin concentration, and liver and kidney func-
tion tests.
6. Evaluation of performance and quality of life status;
before the procedure and 1 day after the last session.
According to the European cooperative oncology group
(ECOG) and the World Health Organization (WHO)
performance scales and quality of life status [5] were esti-
mated as follows, Score 0: Able to carry out normal
activity. Score 1: Restricted in strenuous physical activ-
ity but ambulatory and capable of light work. Score 2:
Ambulatory and capable of self-care. Unable to work
up to 50% of working hours. Score 3: Capable of any
limited self-care, conﬁned to bed or chair >50% ofworking hours. Score 4: Completely disabled. Cannot
carry out self-care and conﬁned to bed or chair. Increas-
ing score means more deterioration.
7. Computed Spiral Tomography and Virtual Bronchos-
copy to measure the length and size of the lesion before
the interventional bronchoscopy according to Ferretti
et al. [6].
8. Flow–volume loop ventilatory function testing accord-
ing to Braman and Abu-Hijleh [7]: It was performed
for all subjects by using computerized pulmonary func-
tion apparatus (ZAN 100, computerized pulmonary
function apparatus). PFTs were done before the inter-
ventional bronchoscopy and 1 day after the last session.
The following parameters were obtained: FEV1: Forced
expiratory volume in the ﬁrst second of the beginning of
Figure 2 (a) CT chest mediastinal window demonstrating an irregular mass centered at the right hilum. (b) Virtual bronchoscopy
showing occlusion of right main bronchus. (c) Fiberoptic bronchoscopic view showing polypoidal mass in the right main bronchus with
smooth glistening surface. (d) Electrocautery forceps coagulate and cut the lesion. (e) Bronchoscopic view after the removal of mass
leaving areas of blanching surface.
504 R.M.M. Hussein et al.expiration as an absolute value and percentage of pre-
dicted for age, sex, length and weight. FVC: Forced vital
capacity, absolute value and percentage of predicted.
FEV1/measured FVC ratio.
9. Arterial blood gases analysis: This was done before and
after the interventional modality according to Lee et al.
[8].
10. Interventional bronchoscopic modalities Reichle et al.
[9] and Van Boxem et al. [10]: Procedures were per-
formed under general anesthesia. The ﬂexible scope
was either passed via an endotracheal tube or through
the rigid bronchoscope. Interventional bronchoscopic
modalities; APC, endobronchial electrosurgery (EES),
core out, and dilatation are used singly or in combina-
tion according to the obstructing lesion. General anes-
thesia technique for interventional bronchoscopy is a
total intravenous anesthesia, consisting of hypnotic
action, analgesia and neuromuscular relaxation. Propo-
fol is a hypnotic drug that was used in a dose of (1–2 mg/
kg) for induction and in a dose of (6–10 mg/kg/h) for themaintenance of anesthesia. Analgesia and muscle relax-
ation were achieved using fentanyl and succinylcholine.
During rigid bronchoscopy, ventilation may be assisted,
controlled (IPPV) or manual by hand bag and per-
formed while high ﬂow of air/oxygen is applied through
the side port of the rigid bronchoscope. Adequate mon-
itoring is critical to recognize and prevent respiratory or
cardiovascular complications. Intraoperative monitor-
ing included continuous pulse oxymetry during every
procedure that is carried out under sedation. Further-
more, electrocardiography, and intermittent noninvasive
measurement of blood pressure were performed. With
the electrocautery, the monoplar probe was pressed
against the tumor base and applying 20–40 W of energy
until sufﬁcient blanching was apparent. The patient was
contacted with a metallic plate near the area of electro-
cautery application. Inspired oxygen concentrations
were kept at 30% if possible. The pulsed mode and
low inspired oxygen concentrations were chosen to
minimize the risk of unintentional penetrating injury
Figure 3 (a) CT chest pulmonary window, showing intra tracheal lesion. (b) Coronal CT cut showing soft tissue attenuation polypoidal
mass demonstrated arising from the right side of the tracheobronchial junction. (c) Virtual bronchoscopy view, demonstrating polypoidal
mass at lower trachea obscuring right main bronchus with smooth lobulated outline. (d) Bronchoscopic view of trachea showing large
mass lesion encapsulated nearly occupying the whole tracheal lumen. (e and f) Electrocautery probe (forceps) at site of lesion during
coagulation of the bleeding site and achievement of hemostasis respectively.
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removed mechanically or with suction. In the cases of
bulky tumors, electrocautery was used to coagulate the
tumor base to shut off vascular structures and to reduce
the risk of bleeding when tumor tissue was mechanically
removed. During treatment with APC, the operator acti-
vates the argon gas source and the high frequency surgi-
cal unit together in an intermittent way, so that the
argon gas passes in the APC probe to be ionized at its
distal end by the tungsten electrode. Thereby, a high fre-
quency electrical energy was transmitted to the tissues
without contact. The argon gas ﬂow is set at a rate of
0.5–2 L/m and the electrical power from 30 to 50 W.
The power settings and the argon gas ﬂow could be
increased or decreased by the use of an up and down
switch. At retreatment session continued until >75%
reopening of the normal airway lumen had beenachieved, or 30 min treatment time elapsed. If there
was insufﬁcient reopening due to probable extra luminal
compression the session was terminated.
The frequency and intervals of interventional sessions were
recorded in each patient besides the time taken in each session
and the complications due to the procedure. However, follow
up bronchoscopywas routinely done 1 week after each interven-
tional session for evaluation of the changes in the size of the le-
sion,moreover, removal of the devitalized tissues and debris was
also the objective of follow up bronchoscopy in these cases.
Judgement about the degree of reconstruction of the pa-
tency of airways was evaluated according to Reitchle et al.
[9] as follows:
(A) Complete success: complete ablation of the endobron-
chial lesion.
Figure 4 (a) CTchestmediastinal viewdemonstrating complete collapseof the right lungand intra-tracheal lesion. (b)Virtualbronchoscopy
showing endobronchial mass obliterating lumen of rightmain bronchus. (c) Bronchial view showingmass with lobulated outline, bleed easily
on touch extending distally into right main bronchus. (d) Bronchoscopic view of trachea and right main oriﬁce after partial removal of the
obstructing lesion. (e) Bronchoscopic view of trachea and right main oriﬁce after partial removal of the obstructing lesion.
506 R.M.M. Hussein et al.(B) Partial success: more than 50% re-opening of the airway
lumen.
(C) No success: no decrease in the size of the endo-bronchial
lesion or less than 50% reopening of the airway lumen.-
Patients outcome was assessed according to the ﬁndings
of follow up bronchoscopy into
A. Favorable outcome: complete successful reconstruction
of airway patency.
B. Unfavorable outcome: partial and/or no success in
reconstruction of airway patency.
Statistical analysis
The demographic, clinical, radiological, physiological and
pathological data were gathered together with the patient
outcome and were tabulated, coded, entered and checked
to an Epi-info ﬁle using Epi-info version 6.02 computerpackages. Data were summarized using; the arithmetic mean
as an average describing the central tendency of observa-
tions, the standard deviation (S.D.) as a measure of disper-
sion of the results around the mean, and the number of
observations for each variable studied (N).
Comparison of means: Student’s t-test, the Chi-square test
(X2) and linear regression test. Level of signiﬁcance: For all the
above-mentioned statistical tests, the threshold of signiﬁcance
is ﬁxed at the 5% level (P-value), a P-valueP 0.05 indicates
non-signiﬁcant results, aP-value < 0.05 indicates signiﬁcant re-
sults, and a P-value < 0.001 indicates highly signiﬁcant results.
Results
The number of session(s) of endobronchial therapy ranged
from 1 to 4, with a median of two sessions applied to sixteen
patients (55.2%). One session was applied to three patients
Table 1 Number of session(s) of endobronchial therapy applied
to the studied patients.
Number of sessions Number of patients Percentage (%) Median
1 3 10.3 2
2 16 55.2
3 7 24.2
4 3 10.3
Prognostic Factors for Bronchoscopic Electrocautery 507while four sessions were applied to three patients only
(Table 1).
Table 2 shows that the presence of comorbidities and longer
duration of symptoms and longer duration of tracheal intuba-
tion are associated with unfavorable outcome. Site of central
airway obstruction has non-signiﬁcant impact on patient
outcome.Table 2 The impact of patient related factors on the outcome of en
Patient related factors Favorable outcome
No = 17 %
Presence of co-morbidities
Present 5 29.4
No comorbidities 12 70.6
Site of CAO
Trachea 6 35.3
Rt. Main bronchus 4 23.5
Lt. main bronchus 2 11.8
Bronchus intermedius 3 17.6
Rt or Lt. labor bronchi 1 5.9
Trachea and Rt. Main bronchus 1 5.9
Duration of symptoms (in weeks) 2.71 ± 1.2
Duration of intubation (in days) 9.5 ± 0.7
Table 3 Impact of factors related to the lesion on the outcome of
Factors related to the lesion Favorable outcome
No = 17 (58.6%)
No %
Etiology of CAO
Malignant 12 70.6
Non-malignant 5 29.4
Presence of lung collapse
Presence of collapse 1 5.9
No collapse 16 94.1
Bronchoscopic appearance of the lesion
Polypoidal/exophytic or pedunculated 12 70.6
Submucosal 5 29.4
Localization of the lesion
Localized 12 70.6
Not localized 5 29.4
Size of the lesion
<3 cm3 16 94.1
>3 cm3 1 5.9
Length of the lesion (cm) 25.82 ± 5.6Table 3 shows that the presence of lung collapse, submuco-
sal lesions, diffuse affection of the airway wall, and increased
length and size of the lesion more than 3 cm3 are all associated
with unfavorable outcome. Etiology of CAO whether malig-
nant or non-malignant has no impact on the outcome of endo-
bronchial therapy. The total number of cases with favorable
outcome is 17 patients (58.6%).
Table 4 shows that the type of the technique used in endo-
bronchial therapy whether Argon Plasma Coagulation, Elec-
trocautery or both have non-signiﬁcant impact on the
outcome of endobronchial therapy. The use of multiple thera-
peutic endobronchial modalities had higher frequency of
favorable patient outcome (76.5%).
Table 5 shows that there is highly signiﬁcant improvement
of dyspnea, cough and hemoptysis scores after endobronchial
therapy. There is also a highly signiﬁcant improvement of per-
formance scale and pulmonary function parameters after
endobronchial therapy.dobronchial therapy.
Unfavorable outcome Total = 29 P-value
No = 12 %
10 83.3 15 0.004*
2 16.7 14
3 25 9 0.85 NS
2 16.7 6 0.98 NS
5 41.7 7 0.15 NS
0 0.0 3 0.24 NS
2 16.7 3 0.55 NS
0 0 1 0.85 NS
4.92 ± 2.0 0.0011*
14.75 ± 3.0 0.03* Sig.
endobronchial therapy.
Unfavorable outcome
No = 12 (41.4%)
Total = 29 P-value
%
21 75 21 0.87
8 25 8
9 66.7 9 <0.001*
20 33.3 20
15 25 15 0.015*
14 75 14
12 0.0 12 <0.001**
17 100 17
19 25 19 <0.001**
10 75 10
40.5 ± 4.4 <0.001**
Table 4 The impact of the technique used in endobronchial therapy on patient outcome.
Technique used Favorable outcome No = 17 (58.6%) Unfavorable outcome No = 12 (41.4%) Total = 29 P-value
No % No %
Type of the technique
APC 8 47.1 7 58.3 15 0.54
EES 8 47.1 4 33.3 12 0.7
Both modalities 1 5.9 1 8.4 2 0.62
Number of modalities
Single modality 4 23.5 7 58.3 11 0.13
Multiple modalities 13 76.5 5 41.7 18
Table 5 Dyspnea, cough and hemoptysis scores and perfor-
mance scales of patient candidates for interventional bron-
choscopy before and after procedures.
Variables Before
Mean ± SD
After
Mean ± SD
P-value
Dyspnea score 3.28 ± 0.75 1.62 ± 0.68 <0.001
Hemoptysis score 1.28 ± 1.4 0.69 ± 0.26 <0.001
Cough score 1.79 ± 0.41 0.79 ± 0.41 <0.001
Performance scale 2.83 ± 1.26 1.52 ± 1.33 <0.001
Pulmonary function parameters
FEV1% 52.34 ± 18.23 72.14 ± 19.65 <0.001
FVC% 57.57 ± 24.54 73.72 ± 25.39 <0.001
FEV1/FVC 67.3 ± 19.9 77.52 ± 16.58 <0.001
Table 6 The signiﬁcance of some independent factors that
impact the outcome of patients with central airway obstruction
undergoing interventional bronchoscopy.
Independent variables Coeﬃcient St. error T P value
Constant 0.8290
Presence of collapse 0.2917 0.1058 2.756 0.011*
Duration of symptoms 0.05427 0.02178 2.492 0.0200*
Length of lesion 0.02552 0.00632 4.039 0.0005*
Localized to wall 0.2419 0.1109 2.181 0.0392*
508 R.M.M. Hussein et al.Using the linear regression analysis of independent factors
affecting the patient outcome; the length of the lesion was
the most independent factor affecting outcome (P= 0.0005)
followed by the presence of collapse (P= 0.011), duration of
symptoms (P= 0.02) and lastly lesion localization
(P= 0.039) whether localized or diffuse Table 6.
Discussion
Therapeutic bronchoscopy has offered several alternatives to
conventional therapy to overcome endobronchial obstruction
which has a central location in 50% of patients with lung can-
cer. These bronchoscopic modalities can be life saving, offer
clinical stability that may allow additional cancer treatment
[11].
In interventional pulmonology, various available methods
can currently be applied. Hot techniques achieve rapid hemos-
tasis enabling mechanical debulking of obstructing tumors.
These combinations of techniques have become the corner-stone approach for immediate recanalization. Cryotherapy,
brachytherapy and PDT are, therefore, less appropriate.
Electrocautery and argon plasma coagulation are straight-
forward techniques enabling simpler clinical application than
Nd-YAG laser. From the clinical perspective, immediate
symptomatic relief by tumor coagulation using electrocautery
followed by mechanical debulking is straightforward and has
been the accepted consensus strategy [12].
Patients were enrolled in this study after the completion of
chemotherapy and/or radiotherapy course(s) or not receiving
them at all, thus the changes in their QOL are solely on the ba-
sis of re-establishment of central airway patency.
In this work, co-morbidities were found in 15/29 (51.72%)
of all the studied patients, COPD was the most common ﬁgure
among them. These co-morbidities, longer duration of symp-
toms and longer duration of mechanical ventilation were sig-
niﬁcantly associated with unfavorable outcome (Table 2).
Smoking, chronic obstructive pulmonary disease (COPD)
and malignant obstruction of the airways are commonly found
to be a leading cause of impact on patient outcome in many
studies, furthermore, in previous studies; some of their patients
had coexisting moderate-to-severe COPD and still showed
physiologic and clinical improvement after therapeutic bron-
choscopic resection of their obstructive large airway lesions
[10].
In the current study, number of sessions ranged from 1 to 4,
with a median of two sessions (Table 1) each lasting about
30 min. The interval between the sessions during the course
of this study was 1 week in the majority of cases and this inter-
val was also recommended [12]. Morice et al. [4] and Reichle
et al. [9] reported a lower mean of session number being 1.2
and 1.4, respectively. On the contrary, the mean number of ses-
sions reported was relatively higher than current work number
of sessions being 3.5 sessions [13]. Yasuo et al. [14] treated post
intubation granulation tissue using APC with a session number
range 3–4. The experience of Keller et al. [15] was unique as
they performed APC in most of their series in only one session
but did not deny that in a few situations, they may be in need
for up to ﬁve sessions. On the other hand, the range of dura-
tion of each APC session was relatively more than Crosta
et al. [13] being 15–40 min in their experience. Mohammad
et al. [16], reported a need for a number of APC sessions rang-
ing between 1 and 4 with a mean of two to achieve the required
palliative effect with a mean duration of 45 min in each session
(Fig. 5).
In this study, favorable outcome was linked to complete suc-
cess (e.g. complete ablation of the endobronchial lesion), while
partial and/or no success in the reconstruction of airway patency
Figure 5 (a and b) Virtual bronchoscopy view into trachea; (a) at the site of stenosis and (b) below the narrowed segment, when the
trachea had regained normal caliber. (c) Coronal CT cut demonstrating the narrowest diameter of 8.9 mm and post stenotic diameter of
21.4 mm. (d) Fiberoptic bronchoscopy view showing the pin point tracheal stenosis. (e) Argon plasma coagulation probe and rigid
bronchoscope at the stenotic segment. (f) Bronchoscopic view of trachea after removal of granulation tissue and rigid bronchoscopic
dilatation.
Prognostic Factors for Bronchoscopic Electrocautery 509was interpreted as unfavorable prognosis. Complete recanaliza-
tion was achieved in (58.6%) while unfavorable outcome ac-
counted for (41.4%) among all the studied patients (Table 3).
The success rate recorded in this study was comparable to
the success rate reported by Vergnon et al. [17] and Yousef
[18], who achieved (65%) and (55%) success rates with cryo-
therapy respectively. Macho et al. [19] reported that, of the
75 patients who underwent endobronchial recanalization by la-
ser resection, in 14% no recanalization was achieved, in 50%
partial (>50% of the lumen) recanalization was obtained,
while in 36% full opening of the occluded bronchus proved
possible. In the study of Lyu et al. [20] successful recanaliza-
tion, with cryotherapy, was achieved in 11 patients (37%),
and partially successful response was achieved in 15 patients(50%). Reichle et al. [9] reported a lower incidence of complete
recanalization (7%) and (40%) failure rate with APC treat-
ment. This result may be explained by an inexperienced bron-
choscopist as they reported several complications with
technical aspects or severe underlying disease and large tumor
size, and deep extension of the lesion.
In the study of Mohammad et al. [16], the success rate of
the bronchoscopic modalities in reconstruction of the patency
of the airways was only considered when more than 50% of
the visible tumor is destroyed. He achieved 85% success rate,
partial recanalization in 15% of cases, with no failure rate.
This ﬁnding may clarify the cause of higher rates of success
in his work as in the current study complete recanalization
was considered only if 100% patency was restored.
510 R.M.M. Hussein et al.In this work; on studying of the impact of factors related to
the endobronchial lesion on patient outcome; there was no sig-
niﬁcance in success between malignant and non-malignant eti-
ologies of centrally obstructing lesions (Table 3). In agreement
with Colt [21] opinion, patients with benign causes of airway
obstruction may also present too late. The interventional bron-
choscopist’s mission is ﬁrst to restore airway patency, and sec-
ond to assess the potential for curative bronchoscopic or open
surgical treatment in those patients. Emergency interventional
procedures in this setting are usually life saving, allowing pa-
tients to calmly participate in subsequent decision making
regarding further treatment options.
In this work, post-intubation and tracheostomy tracheal
stenosis account the most popular reasons of non-malignant
CAO (6/8 cases). For all of them, APC and bronchoscopic
dilatation were applied. In the present study; it was found that
presence of lung collapse, submucosal lesions, larger length
and size of the lesion with diffuse affection of the airway wall
are all associated with unfavorable outcome. Coulter and
Mehta [22] found that lesions found to be most favorable to
interventional therapeutic bronchoscopy were polypoid in
morphology and were attached to the airway by a stalk. This
characteristic ﬁnding allowed for the total ensnarement of
the lesion with complete removal in one piece. In addition to
the immediate difﬁculties of treating sessile lesions, late com-
plications can occur as well. The various settings of mode,
power, and duration of application make it difﬁcult to predict
the depth of tissue destruction.
Supportive results were published in many previous studies,
as tumors >1 cm, with >3 mm invasion of the bronchial mu-
cosa and invisible distal tumor margin are unlikely to be cured
by bronchoscopic treatment [23]. In a pilot study, Van Boxem
et al. [10] reported a complete response to EBES in 10 of 13
patients with endobronchial lesions that were <1 cm2. Their
study suggests that EBES may be an effective alternative even
in the treatment of carcinoma in situ.
In the present study, it was found that the type of the tech-
nique used in endobronchial therapy whether electrocautery or
argon plasma coagulation or both had non-signiﬁcant impact
on patient outcome. This can be explained by the fact that
both modes of endobronchial therapy produce the same effect
of thermal electrocoagulation, one of them (electrocautery) ap-
plies the contact mode while the other (APC) applies the non
contact mode of tissue coagulation. In the present study, the
use of multiple modalities of endobronchial therapy has statis-
tically non-signiﬁcant higher frequency of favorable outcome
(76.5%) (Table 4). The multiple modalities used in this work
are; tissue core out, rigid bronchoscopic dilatation, APC and
EES.
In the present work there was highly signiﬁcant
improvement of dyspnea, cough and hemoptysis scores
after endobronchial therapy. There was also highly signiﬁ-
cant improvement of performance scale and pulmonary
function parameters after endobronchial therapy (Table 5).
Amjadi et al. [24] concluded that in the appropriate patient
population, interventional bronchoscopy can provide a sig-
niﬁcant improvement of respiratory symptoms and quality
of life in malignant airway obstruction. Mohammad et al.
[16] reported signiﬁcant improvement in FVC% even after
the ﬁrst session of APC treatment with a signiﬁcant
improvement in FEV1% and FEV1/FVC% but only after
the last session.Using the linear regression analysis of independent factors
affecting the patient outcome; it was found that; length of
the lesion was the most independent factor affecting the out-
come (P= 0.0005), followed by the presence of collapse
(P= 0.011), duration of symptoms (P= 0.02) and lastly le-
sion localization (P= 0.039) whether localized or diffuse (Ta-
ble 6). This result agrees with that of Coulter and Mehta [22].
Conclusion
Argon plasma coagulation (APC) and electrocautery are safe
and effective modalities in alleviating symptoms, improving
performance, quality of life and ventilatory function parame-
ters in patients with central airway obstruction. For favorable
outcome, selection of patients with central airway obstructing
lesions candidates for bronchoscopic argon plasma coagula-
tion and/or electrocautery should rely on several factors; age,
duration of symptoms, performance scale, co-morbidities,
pre-therapeutic FEV1%, presence of lung collapse, and length
of the obstructing lesion, moreover its shape and localization.
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